Yu et al. revealed that FMT restored GM balance in CRC mice, promoting the infiltration of CD8+ T cells, CD4+ T cells, and CD49b+ NK cells while suppressing Foxp3+ Treg cells, thereby effectively inhibiting CRC progression (Yu et al., 2023). The gene discussed is ITGA2; the disease is colorectal carcinoma.